The applications are for uses of under REACH regulation:
● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Sanofi Pasteur
● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Merck Bio development SAS and FUJIFILM Diosynth Biotechnologies UK Limited
● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Swords Laboratories
● one use of 4-nonylphenol, branched and linear, ethoxylated (EC -, CAS -) by Cytiva Sweden AB
● three uses (1, 2 and 3) of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by SEBIA
● one use of 4-nonylphenol, branched and linear, ethoxylated (EC -, CAS) by SEBIA;
● two uses (1 and 2) of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by DIAGNOSTICA STAGO.
● one use of sodium chromate (EC 231-889-5, CAS 7775-11-3) by Ariston Thermo SpA;
● one use of chromium trioxide (EC 215-607-8, CAS 1333-82-0) by Tata Steel UK Ltd
● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Roche Diagnostics GmbH and
● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Nuova Ompi S.r.l. unipersonale.
Reference: https://echa.europa.eu/applications-for-authorisation-previous-consultations
If this regulation is applicable to you and you are interested in knowing more about this topic and available solutions, then schedule a free consult with our experts.